One interesting feature to consider in anti-cancer therapy is the recent use of anti-cancer compounds with clinical efficacy as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) that selectively induces the apoptosis pathway in tumor cells leading to tumor cell death. This evidence concerns the gene TNFSF10 and cancer.